CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 103 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,237,041 | -14.2% | 790,166 | -1.3% | 0.00% | 0.0% |
| Q2 2023 | $10,763,101 | -20.7% | 800,826 | -2.2% | 0.00% | -33.3% |
| Q1 2023 | $13,578,987 | -15.5% | 818,998 | -5.2% | 0.00% | -25.0% |
| Q4 2022 | $16,061,565 | +36.6% | 863,525 | -5.8% | 0.00% | +33.3% |
| Q3 2022 | $11,759,000 | +235.0% | 916,396 | +83.0% | 0.00% | +200.0% |
| Q2 2022 | $3,510,000 | -25.7% | 500,766 | -12.1% | 0.00% | 0.0% |
| Q1 2022 | $4,722,000 | +42.9% | 569,542 | +16.7% | 0.00% | 0.0% |
| Q4 2021 | $3,305,000 | -4.9% | 488,217 | -25.5% | 0.00% | 0.0% |
| Q3 2021 | $3,475,000 | -2.7% | 655,517 | +5.5% | 0.00% | 0.0% |
| Q2 2021 | $3,573,000 | +21.9% | 621,474 | -2.3% | 0.00% | 0.0% |
| Q1 2021 | $2,932,000 | +40.2% | 635,909 | +1.6% | 0.00% | – |
| Q4 2020 | $2,091,000 | +63.6% | 626,022 | +45.5% | 0.00% | – |
| Q3 2020 | $1,278,000 | -34.1% | 430,333 | +2.5% | 0.00% | -100.0% |
| Q2 2020 | $1,939,000 | +17.7% | 419,806 | -1.9% | 0.00% | 0.0% |
| Q1 2020 | $1,647,000 | +1.4% | 427,802 | -1.2% | 0.00% | – |
| Q4 2019 | $1,624,000 | -21.1% | 433,126 | +11.7% | 0.00% | -100.0% |
| Q3 2019 | $2,058,000 | +51.9% | 387,694 | +9.9% | 0.00% | – |
| Q2 2019 | $1,355,000 | -42.2% | 352,902 | -23.2% | 0.00% | -100.0% |
| Q1 2019 | $2,344,000 | +265.7% | 459,751 | +37.6% | 0.00% | – |
| Q4 2018 | $641,000 | -45.0% | 334,078 | +8.3% | 0.00% | – |
| Q3 2018 | $1,166,000 | +35.9% | 308,580 | +12.3% | 0.00% | – |
| Q2 2018 | $858,000 | +51.1% | 274,813 | +15.7% | 0.00% | – |
| Q1 2018 | $568,000 | -68.0% | 237,425 | -47.7% | 0.00% | – |
| Q4 2017 | $1,777,000 | +229.7% | 454,374 | +112.5% | 0.00% | – |
| Q3 2017 | $539,000 | -7.9% | 213,837 | +0.9% | 0.00% | – |
| Q2 2017 | $585,000 | +333.3% | 211,979 | +206.4% | 0.00% | – |
| Q1 2017 | $135,000 | +92.9% | 69,176 | +3.6% | 0.00% | – |
| Q4 2016 | $70,000 | -9.1% | 66,772 | -6.0% | 0.00% | – |
| Q3 2016 | $77,000 | +30.5% | 71,038 | -14.7% | 0.00% | – |
| Q2 2016 | $59,000 | -79.3% | 83,266 | -65.8% | 0.00% | – |
| Q1 2016 | $285,000 | -56.4% | 243,198 | -8.9% | 0.00% | – |
| Q4 2015 | $654,000 | -18.6% | 266,820 | -0.2% | 0.00% | – |
| Q3 2015 | $803,000 | -37.4% | 267,475 | -13.8% | 0.00% | – |
| Q2 2015 | $1,282,000 | +221.3% | 310,422 | +236.7% | 0.00% | – |
| Q1 2015 | $399,000 | +45.6% | 92,201 | -0.0% | 0.00% | – |
| Q4 2014 | $274,000 | +23.4% | 92,241 | +37.8% | 0.00% | – |
| Q3 2014 | $222,000 | -64.5% | 66,956 | -73.0% | 0.00% | – |
| Q2 2014 | $626,000 | +124.4% | 247,790 | +101.1% | 0.00% | – |
| Q1 2014 | $279,000 | +40.9% | 123,237 | +21.6% | 0.00% | – |
| Q4 2013 | $198,000 | -68.0% | 101,363 | -50.0% | 0.00% | – |
| Q3 2013 | $618,000 | – | 202,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |